Urinary Metabolomics-Driven Discovery of Metabolic Markers and Molecular Subtyping in Liver Cancer
Xiaoling Zhou(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Hongsheng Lin(Guangxi University), Minpeng Li(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Fuli Long(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Yunyong Wang(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Rongzhen Zhang
Cited by 1
Related Papers
Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
|World Journal of Surgical Oncology|2022|115
The lncRNA MALAT1/miR-30/Spastin Axis Regulates Hippocampal Neurite Outgrowth
|Frontiers in Cellular Neuroscience|2020|31
Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases
|Medical Science Monitor|2018|23
LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia
|Scientific Reports|2022|12
Effect of Immune 2 with highly active antiretroviral treatment on immune function of HIV/AIDS patients with poor immune reconstitution
|China Journal of Chinese Materia Medica|2013|6